| Analysis | Metabolite Name | Measured Value | Units | Source |
|---|---|---|---|---|
| GCMS positive ion mode | lyxitol | 584.567477 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 770.6478454 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 809.2402058 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 820.6616665 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 835.9070711 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 848.702803 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 848.7052594 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 867.8266811 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 972.3840134 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 989.7699089 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 998.9045136 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1066.590597 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1085.640025 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1117.861507 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1120.741675 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1124.438225 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1125.972422 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1133.571506 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1136.980625 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1150.711206 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1156.90153 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1169.822785 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1193.612945 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1206.728065 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1220.772685 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1222.557669 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1228.637394 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1256.218847 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1286.392528 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1373.719665 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1406.69888 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1408.023423 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1418.199471 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1425.094603 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1442.217335 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1455.674856 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1498.375155 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1503.281088 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1503.911989 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1515.404902 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1536.979946 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1600.742088 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1603.022553 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1628.639005 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1652.335114 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1721.423819 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1725.070996 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1743.425264 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1775.14294 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1824.410158 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1883.817696 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1901.314241 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1957.459069 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 1992.534298 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 2222.230622 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 2303.839092 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 2851.002178 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 3308.941172 | Peak area | Group 1 - Human Serum |
| GCMS positive ion mode | lyxitol | 4198.097598 | Peak area | Group 1 - Human Serum |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|